Trigeminal neuralgia
Views: 66DOI:
https://doi.org/10.48208/HeadacheMed.2025.37Keywords:
Trigeminal Neuralgia, Neuropathic pain, Microvascular compression, NeuromodulationAbstract
Background
Trigeminal neuralgia (TN) is a chronic neuropathic pain disorder characterized by recurrent, severe, unilateral facial pain in the distribution of one or more branches of the trigeminal nerve.
Discussion
Although its prevalence is relatively low, TN remains one of the most debilitating pain syndromes due to its intensity and unpredictable nature. This review aims to summarize current knowledge on the pathophysiology, diagnostic criteria, and management of trigeminal neuralgia, including both pharmacological and surgical options.
Conclusions
Trigeminal neuralgia remains a challenging condition requiring an individualized, multidisciplinary approach.
Downloads
References
1. Cruccu G, Bonamico L, Zakrzewska J. Cranial neuralgias. In: Nappi G, Moskowitz M, editors. Handb Clin Neurol, vol. 97, 2010, p. 663–78. Doi:10.1016/S0072-9752(10)97056-5.
2. Tereshko Y, Dal Bello S, Lettieri C, Belgrado E, Gigli GL, Merlino G, et al. Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review. Toxins (Basel) 2024;16:500. Doi:10.3390/toxins16110500.
3. Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol 2021;21:392–402. Doi:10.1136/practneurol-2020-002782.
4. Ashina S, Robertson CE, Srikiatkhachorn A, Di Stefano G, Donnet A, Hodaie M, et al. Trigeminal neuralgia. Nat Rev Dis Primers 2024;10:39. Doi:10.1038/s41572-024-00523-z.
5. De Stefano G, Litewczuk D, Mollica C, Di Pietro G, Galosi E, Leone C, et al. Sex differences in trigeminal neuralgia: a focus on radiological and clinical characteristics. Neurological Sciences 2023;44:4465–72. Doi:10.1007/s10072-023-06923-5.
6. Sjaastad O, Fredriksen TA, Stolt-Nielsen A, Salvesen R, Jansen J, Pareja JA, et al. Cervicogenic headache: a clinical review with special emphasis on therapy. Funct Neurol 1997;12:305–17.
7. Lambru G, Rantell K, O’Connor E, Levy A, Davagnanam I, Zrinzo L, et al. Trigeminal neurovascular contact in SUNCT and SUNA: a cross-sectional magnetic resonance study. Brain 2020;143:3619–28. Doi:10.1093/brain/awaa331.
8. Lambru G, Stubberud A, Rantell K, Lagrata S, Tronvik E, Matharu MS. Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis. J Neurol Neurosurg Psychiatry 2021;92:233–41. Doi:10.1136/jnnp-2020-323999.
9. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995;45:1294–6. Doi:10.1212/WNL.45.7.1294.
10. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D’Aleo G, et al. The prevalence of pain in multiple sclerosis. Neurology 2004;63:919–21. Doi:10.1212/01.WNL.0000137047.85868.D6.
11. Pergolizzi J V., LeQuang JA, El-Tallawy SN, Wagner M, Ahmed RS, Varrassi G. An update on pharmacotherapy for trigeminal neuralgia. Expert Rev Neurother 2024;24:773–86. Doi:10.1080/14737175.2024.2365946.
12. Chow A, Haider I, Athanaselos A, Patel M. In-Hospital Management of Acute Trigeminal Neuralgia Pain Crises. Clin Med Res 2024;22:215–21. Doi:10.3121/cmr.2024.1945.
13. Muñoz-Vendrell A, Teixidor S, Sala-Padró J, Campoy S, Huerta-Villanueva M. Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases. Cephalalgia 2022;42:1031–8. Doi:10.1177/03331024221092435.
14. Mian MU, Afzal M, Butt AA, Ijaz M, Khalil K, Abbasi M, et al. Neuropharmacology of Neuropathic Pain: A Systematic Review. Cureus 2024. Doi:10.7759/cureus.69028.
15. Rana MH, Khan AAG, Khalid I, Ishfaq M, Javali MA, Baig FAH, et al. Therapeutic Approach for Trigeminal Neuralgia: A Systematic Review. Biomedicines 2023;11:2606. Doi:10.3390/biomedicines11102606.
16. Cruccu G, Di Stefano G, Truini A. Trigeminal Neuralgia. New England Journal of Medicine 2020;383:754–62. Doi:10.1056/NEJMra1914484.
17. Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T, et al. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol 2020;19:784–96. Doi:10.1016/S1474-4422(20)30233-7.
18. Zhao X, Ge S. The efficacy and safety of gabapentin vs. carbamazepine in patients with primary trigeminal neuralgia: A systematic review and meta-analysis. Front Neurol 2023;14. Doi:10.3389/fneur.2023.1045640.
19. Oliveira KM, Barreto ESR, Alencar VB, Lins-Kusterer LEF, Azi LMT de A, Kraychete DC. The efficacy of botulinum toxin in neuropathic pain: a systematic review. Br J Pain 2024;18:388–402. Doi:10.1177/20494637241254191.
20. Obermann M. Recent advances in understanding/managing trigeminal neuralgia. F1000Res 2019;8:505. Doi:10.12688/f1000research.16092.1.
21. Naderi Y, Rad M, Sadatmoosavi A, Khaleghi E, Khorrami Z, Chamani G, et al. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review. Clin Exp Dent Res 2024;10. Doi:10.1002/cre2.882.
22. Di Stefano G, Truini A, Cruccu G. Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. Drugs 2018;78:1433–42. Doi:10.1007/s40265-018-0964-9.
23. Gomes-da Silva de Rosenzweig P, Pastrana-Brandes S, Merikansky-Gerson S, Victoria-Garcia LO, Curtius-Caruso MS, Carrillo-Ruiz JD. Factors associated with outcomes following microvascular decompression for the treatment of primary trigeminal neuralgia in adults: a systematic review and meta-analysis. J Dent Anesth Pain Med 2024;24:227. Doi:10.17245/jdapm.2024.24.4.227.
24. Okon II, Menon SS, Osama M, Aiman M, Paleare LFF, Eliseo DL-P, et al. Microvascular decompression: a contemporary update. BMC Surg 2025;25:20. Doi:10.1186/s12893-025-02762-7.
25. McBenedict B, Hauwanga WN, Yau MCY, Pogodina A, Singh G, Abdelrahman A, et al. Outcomes of Different Surgical Interventions for Treating Trigeminal Neuralgia: A Review. Cureus 2024. Doi:10.7759/cureus.66724.
26. Khaboushan AS, Maroufi SF, Jarrah N, Moafi M, Sabahi M, Borghei-Razavi H, et al. Comparison of stereotactic radiosurgery and rhizotomy for trigeminal neuralgia: A systematic review and Meta-Analysis. Neurosurg Rev 2025;48:613. Doi:10.1007/s10143-025-03763-z.
27. Trigeminal neuralgia: therapeutic strategies to restore quality of life. J Oral Facial Pain Headache 2024. Doi:10.22514/jofph.2024.024.
28. Branco R, Silva BG, Pereira A, Amorim I, Jacinto J. What Is New and Effective in Treating Refractory Trigeminal Neuralgia? Cureus 2024. Doi:10.7759/cureus.73110.
29. Ta PCP, Dinh HQ, Nguyen K, Lin S, Ong YL, Ariyawardana A. Efficacy of gabapentin in the treatment of trigeminal neuralgia: A systematic review of randomized controlled trials. J Investig Clin Dent 2019;10. Doi:10.1111/jicd.12448.
30. Stern JI, Ali R, Chiang C-C, Robertson CE. Pathophysiology and Management of Refractory Trigeminal Neuralgia. Curr Neurol Neurosci Rep 2025;25:10. Doi:10.1007/s11910-024-01387-2.
31. Latorre G, González-García N, García-Ull J, González-Oria C, Porta-Etessam J, Molina FJ, et al. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology’s Headache Study Group. Neurología (English Edition) 2023;38:S37–52. Doi:10.1016/j.nrleng.2023.04.005.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Stephania Bohórquez-Valderrama, Maria Elena Santillán, Matias Sebastian Corzo , Carlos Federico Buonanotte , Lucas Hector Bonamico (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
